HEADER TRANSCRIPTION/INHIBITOR 14-MAY-18 6DF7 TITLE TAF1-BD2 IN COMPLEX WITH CPD27 (6-(BUT-3-EN-1-YL)-4-(1-METHYL-6- TITLE 2 (MORPHOLINE-4-CARBONYL)-1H-BENZO[D]IMIDAZOL-4-YL)-1,6-DIHYDRO-7H- TITLE 3 PYRROLO[2,3-C]PYRIDIN-7-ONE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSCRIPTION INITIATION FACTOR TFIID SUBUNIT; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: BROMODOMAIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: RABBIT; SOURCE 4 ORGANISM_TAXID: 9986; SOURCE 5 GENE: TAF1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TAF1-BD2, BROMODOMAIN, SMALL MOLECULE INHIBITOR, SBDD, TRANSCRIPTION- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.M.MURRAY REVDAT 2 11-OCT-23 6DF7 1 REMARK REVDAT 1 14-NOV-18 6DF7 0 JRNL AUTH S.WANG,V.TSUI,T.D.CRAWFORD,J.E.AUDIA,D.J.BURDICK, JRNL AUTH 2 M.H.BERESINI,A.COTE,R.CUMMINGS,M.DUPLESSIS,E.M.FLYNN, JRNL AUTH 3 M.C.HEWITT,H.R.HUANG,H.JAYARAM,Y.JIANG,S.JOSHI,J.MURRAY, JRNL AUTH 4 C.G.NASVESCHUK,E.PARDO,F.POY,F.A.ROMERO,Y.TANG,A.M.TAYLOR, JRNL AUTH 5 J.WANG,Z.XU,L.E.ZAWADZKE,X.ZHU,B.K.ALBRECHT,S.R.MAGNUSON, JRNL AUTH 6 S.BELLON,A.G.COCHRAN JRNL TITL GNE-371, A POTENT AND SELECTIVE CHEMICAL PROBE FOR THE JRNL TITL 2 SECOND BROMODOMAINS OF HUMAN TRANSCRIPTION-INITIATION-FACTOR JRNL TITL 3 TFIID SUBUNIT 1 AND TRANSCRIPTION-INITIATION-FACTOR TFIID JRNL TITL 4 SUBUNIT 1-LIKE. JRNL REF J. MED. CHEM. V. 61 9301 2018 JRNL REFN ISSN 1520-4804 JRNL PMID 30289257 JRNL DOI 10.1021/ACS.JMEDCHEM.8B01225 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 21.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 3 NUMBER OF REFLECTIONS : 22754 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.970 REMARK 3 FREE R VALUE TEST SET COUNT : 1131 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.10 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.23 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2587 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2314 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2471 REMARK 3 BIN R VALUE (WORKING SET) : 0.2313 REMARK 3 BIN FREE R VALUE : 0.2342 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.48 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 116 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2089 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 186 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 45.79 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.37 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.92370 REMARK 3 B22 (A**2) : -1.20480 REMARK 3 B33 (A**2) : 2.12850 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.260 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.176 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.152 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.166 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.149 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2214 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3017 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 757 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 380 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2214 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 287 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2693 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.81 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.09 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 23.1005 -0.0456 86.0482 REMARK 3 T TENSOR REMARK 3 T11: -0.0006 T22: -0.0621 REMARK 3 T33: 0.0136 T12: -0.0069 REMARK 3 T13: -0.0326 T23: -0.0168 REMARK 3 L TENSOR REMARK 3 L11: 0.6098 L22: 0.0000 REMARK 3 L33: 1.2777 L12: -0.1635 REMARK 3 L13: 0.1563 L23: 0.1412 REMARK 3 S TENSOR REMARK 3 S11: -0.0483 S12: -0.2143 S13: 0.0721 REMARK 3 S21: 0.0353 S22: 0.1054 S23: -0.0942 REMARK 3 S31: -0.2070 S32: 0.0086 S33: -0.0571 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 20.8424 -19.1090 99.6855 REMARK 3 T TENSOR REMARK 3 T11: -0.0805 T22: -0.0405 REMARK 3 T33: -0.0403 T12: 0.0759 REMARK 3 T13: 0.0206 T23: 0.0174 REMARK 3 L TENSOR REMARK 3 L11: 1.1260 L22: 2.4173 REMARK 3 L33: 3.2711 L12: -0.2767 REMARK 3 L13: -0.4148 L23: 1.5715 REMARK 3 S TENSOR REMARK 3 S11: -0.1472 S12: -0.1312 S13: 0.0239 REMARK 3 S21: 0.1997 S22: 0.2669 S23: -0.0696 REMARK 3 S31: 0.0376 S32: 0.3873 S33: -0.1197 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6DF7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-MAY-18. REMARK 100 THE DEPOSITION ID IS D_1000234514. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-JAN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22773 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 41.914 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.01 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : 2.24300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5I1Q REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS PH 6.5, 28% W/V PEG MME REMARK 280 2,000, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.20750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.91400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.85050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.91400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.20750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 39.85050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1472 REMARK 465 HIS A 1473 REMARK 465 HIS A 1474 REMARK 465 HIS A 1475 REMARK 465 HIS A 1476 REMARK 465 HIS A 1477 REMARK 465 HIS A 1478 REMARK 465 ALA A 1479 REMARK 465 SER A 1480 REMARK 465 ASP A 1481 REMARK 465 TYR A 1482 REMARK 465 LYS A 1483 REMARK 465 ASP A 1484 REMARK 465 ASP A 1485 REMARK 465 ASP A 1486 REMARK 465 ASP A 1487 REMARK 465 LYS A 1488 REMARK 465 GLY A 1489 REMARK 465 SER A 1490 REMARK 465 LEU A 1491 REMARK 465 VAL A 1492 REMARK 465 PRO A 1493 REMARK 465 ARG A 1494 REMARK 465 GLY A 1495 REMARK 465 SER A 1496 REMARK 465 PRO A 1497 REMARK 465 LEU A 1498 REMARK 465 LEU A 1499 REMARK 465 ASP A 1500 REMARK 465 PRO A 1636 REMARK 465 MET A 1637 REMARK 465 THR A 1638 REMARK 465 MET B 1472 REMARK 465 HIS B 1473 REMARK 465 HIS B 1474 REMARK 465 HIS B 1475 REMARK 465 HIS B 1476 REMARK 465 HIS B 1477 REMARK 465 HIS B 1478 REMARK 465 ALA B 1479 REMARK 465 SER B 1480 REMARK 465 ASP B 1481 REMARK 465 TYR B 1482 REMARK 465 LYS B 1483 REMARK 465 ASP B 1484 REMARK 465 ASP B 1485 REMARK 465 ASP B 1486 REMARK 465 ASP B 1487 REMARK 465 LYS B 1488 REMARK 465 GLY B 1489 REMARK 465 SER B 1490 REMARK 465 LEU B 1491 REMARK 465 VAL B 1492 REMARK 465 PRO B 1493 REMARK 465 ARG B 1494 REMARK 465 GLY B 1495 REMARK 465 SER B 1496 REMARK 465 PRO B 1497 REMARK 465 LEU B 1498 REMARK 465 LEU B 1499 REMARK 465 ASP B 1500 REMARK 465 LYS B 1622 REMARK 465 GLU B 1623 REMARK 465 ALA B 1624 REMARK 465 ALA B 1625 REMARK 465 LEU B 1626 REMARK 465 GLU B 1627 REMARK 465 GLU B 1628 REMARK 465 ALA B 1629 REMARK 465 GLU B 1630 REMARK 465 LEU B 1631 REMARK 465 GLU B 1632 REMARK 465 SER B 1633 REMARK 465 LEU B 1634 REMARK 465 ASP B 1635 REMARK 465 PRO B 1636 REMARK 465 MET B 1637 REMARK 465 THR B 1638 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS B1555 CG CD CE NZ REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A4197 DISTANCE = 6.44 ANGSTROMS REMARK 525 HOH A4198 DISTANCE = 7.23 ANGSTROMS REMARK 525 HOH A4199 DISTANCE = 7.62 ANGSTROMS REMARK 525 HOH A4200 DISTANCE = 10.22 ANGSTROMS REMARK 525 HOH B4186 DISTANCE = 6.99 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G9V A 4001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue G9V B 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6DF4 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED TO A DIFFERENT COMPOUND DBREF 6DF7 A 1497 1638 UNP U3KMH2 U3KMH2_RABIT 1498 1639 DBREF 6DF7 B 1497 1638 UNP U3KMH2 U3KMH2_RABIT 1498 1639 SEQADV 6DF7 MET A 1472 UNP U3KMH2 INITIATING METHIONINE SEQADV 6DF7 HIS A 1473 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 HIS A 1474 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 HIS A 1475 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 HIS A 1476 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 HIS A 1477 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 HIS A 1478 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ALA A 1479 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 SER A 1480 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ASP A 1481 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 TYR A 1482 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 LYS A 1483 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ASP A 1484 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ASP A 1485 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ASP A 1486 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ASP A 1487 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 LYS A 1488 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 GLY A 1489 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 SER A 1490 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 LEU A 1491 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 VAL A 1492 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 PRO A 1493 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ARG A 1494 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 GLY A 1495 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 SER A 1496 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 MET B 1472 UNP U3KMH2 INITIATING METHIONINE SEQADV 6DF7 HIS B 1473 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 HIS B 1474 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 HIS B 1475 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 HIS B 1476 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 HIS B 1477 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 HIS B 1478 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ALA B 1479 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 SER B 1480 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ASP B 1481 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 TYR B 1482 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 LYS B 1483 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ASP B 1484 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ASP B 1485 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ASP B 1486 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ASP B 1487 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 LYS B 1488 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 GLY B 1489 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 SER B 1490 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 LEU B 1491 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 VAL B 1492 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 PRO B 1493 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 ARG B 1494 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 GLY B 1495 UNP U3KMH2 EXPRESSION TAG SEQADV 6DF7 SER B 1496 UNP U3KMH2 EXPRESSION TAG SEQRES 1 A 167 MET HIS HIS HIS HIS HIS HIS ALA SER ASP TYR LYS ASP SEQRES 2 A 167 ASP ASP ASP LYS GLY SER LEU VAL PRO ARG GLY SER PRO SEQRES 3 A 167 LEU LEU ASP ASP ASP ASP GLN VAL ALA PHE SER PHE ILE SEQRES 4 A 167 LEU ASP ASN ILE VAL THR GLN LYS MET MET ALA VAL PRO SEQRES 5 A 167 ASP SER TRP PRO PHE HIS HIS PRO VAL ASN LYS LYS PHE SEQRES 6 A 167 VAL PRO ASP TYR TYR LYS VAL ILE VAL ASN PRO MET ASP SEQRES 7 A 167 LEU GLU THR ILE ARG LYS ASN ILE SER LYS HIS LYS TYR SEQRES 8 A 167 GLN SER ARG GLU SER PHE LEU ASP ASP VAL ASN LEU ILE SEQRES 9 A 167 LEU ALA ASN SER VAL LYS TYR ASN GLY PRO GLU SER GLN SEQRES 10 A 167 TYR THR LYS THR ALA GLN GLU ILE VAL ASN VAL CYS TYR SEQRES 11 A 167 GLN THR LEU THR GLU TYR ASP GLU HIS LEU THR GLN LEU SEQRES 12 A 167 GLU LYS ASP ILE CYS THR ALA LYS GLU ALA ALA LEU GLU SEQRES 13 A 167 GLU ALA GLU LEU GLU SER LEU ASP PRO MET THR SEQRES 1 B 167 MET HIS HIS HIS HIS HIS HIS ALA SER ASP TYR LYS ASP SEQRES 2 B 167 ASP ASP ASP LYS GLY SER LEU VAL PRO ARG GLY SER PRO SEQRES 3 B 167 LEU LEU ASP ASP ASP ASP GLN VAL ALA PHE SER PHE ILE SEQRES 4 B 167 LEU ASP ASN ILE VAL THR GLN LYS MET MET ALA VAL PRO SEQRES 5 B 167 ASP SER TRP PRO PHE HIS HIS PRO VAL ASN LYS LYS PHE SEQRES 6 B 167 VAL PRO ASP TYR TYR LYS VAL ILE VAL ASN PRO MET ASP SEQRES 7 B 167 LEU GLU THR ILE ARG LYS ASN ILE SER LYS HIS LYS TYR SEQRES 8 B 167 GLN SER ARG GLU SER PHE LEU ASP ASP VAL ASN LEU ILE SEQRES 9 B 167 LEU ALA ASN SER VAL LYS TYR ASN GLY PRO GLU SER GLN SEQRES 10 B 167 TYR THR LYS THR ALA GLN GLU ILE VAL ASN VAL CYS TYR SEQRES 11 B 167 GLN THR LEU THR GLU TYR ASP GLU HIS LEU THR GLN LEU SEQRES 12 B 167 GLU LYS ASP ILE CYS THR ALA LYS GLU ALA ALA LEU GLU SEQRES 13 B 167 GLU ALA GLU LEU GLU SER LEU ASP PRO MET THR HET G9V A4001 32 HET G9V B4000 32 HETNAM G9V 6-(BUT-3-EN-1-YL)-4-[1-METHYL-6-(MORPHOLINE-4- HETNAM 2 G9V CARBONYL)-1H-BENZIMIDAZOL-4-YL]-1,6-DIHYDRO-7H- HETNAM 3 G9V PYRROLO[2,3-C]PYRIDIN-7-ONE FORMUL 3 G9V 2(C24 H25 N5 O3) FORMUL 5 HOH *186(H2 O) HELIX 1 AA1 ASP A 1501 LYS A 1518 1 18 HELIX 2 AA2 SER A 1525 HIS A 1529 5 5 HELIX 3 AA3 ASP A 1539 ILE A 1544 1 6 HELIX 4 AA4 ASP A 1549 LYS A 1559 1 11 HELIX 5 AA5 SER A 1564 GLY A 1584 1 21 HELIX 6 AA6 SER A 1587 TYR A 1607 1 21 HELIX 7 AA7 TYR A 1607 SER A 1633 1 27 HELIX 8 AA8 ASP B 1502 LYS B 1518 1 17 HELIX 9 AA9 SER B 1525 HIS B 1529 5 5 HELIX 10 AB1 ASP B 1539 ILE B 1544 1 6 HELIX 11 AB2 ASP B 1549 LYS B 1559 1 11 HELIX 12 AB3 SER B 1564 GLY B 1584 1 21 HELIX 13 AB4 SER B 1587 TYR B 1607 1 21 HELIX 14 AB5 TYR B 1607 ALA B 1621 1 15 SITE 1 AC1 14 PRO A1527 PHE A1528 HIS A1530 PRO A1531 SITE 2 AC1 14 VAL A1532 ASN A1533 PHE A1536 MET A1548 SITE 3 AC1 14 TYR A1582 ASN A1583 TYR A1589 HOH A4147 SITE 4 AC1 14 TYR B1607 HIS B1610 SITE 1 AC2 14 HIS A1610 SER A1633 PRO B1527 PHE B1528 SITE 2 AC2 14 HIS B1530 PRO B1531 VAL B1532 ASN B1533 SITE 3 AC2 14 PHE B1536 MET B1548 TYR B1582 ASN B1583 SITE 4 AC2 14 TYR B1589 HOH B4142 CRYST1 52.415 79.701 83.828 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019079 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012547 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011929 0.00000